fashion -WSS

fashion

author：comprehensive 2025-10-02 18:50:10 - browse：7925

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — Two days after similar decisions in the U.S. and U.K., regulators in Europe on Friday recommended that the approval of Eli Lilly’s diabetes drug Mounjaro be widened to include obesity.

The ruling from a committee of the European Medicines Agency now goes to the European Commission, which makes the final decision but almost always follows the EMA’s guidance.

Mounjaro, known scientifically as tirzepatide, is one of an emerging class of drugs that target receptors of the GLP-1 hormone, and sometimes other molecules, and that have had dramatic effects on weight loss. Doctors have been prescribing the diabetes drugs off-label for obesity, but having specific authorization could streamline the process of getting the medicines.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Nurses recount patients attacks

explore

WSS

How to make over

Readout Newsletter: Bluebird, CVS, Contineum

AstraZeneca to buy developer of next

PBMs are inflating the cost of generic drugs. They must be reined in

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Intermittent fasting comes with a heart risk? Not so fast

knowledge

fashion

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Physicians and social media: If you see something, say something?

Dobbs anniversary: the lost opportunity of abortion as health care

California store owner shot dead in dispute over displaying Pride flag: Police

Supreme Court strikes down use of affirmative action

California store owner shot dead in dispute over displaying Pride flag: Police

State Dept. review finds Biden bears some blame for Afghanistan failures

Listen: Vivek Ramaswamy's star turn & leaky drug data

leisure time

Listen: Vivek Ramaswamy's star turn & leaky drug data

PBMs are inflating the cost of generic drugs. They must be reined in

FDA advisory panel to debate high blood pressure devices

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Intermittent fasting comes with a heart risk? Not so fast

How the drug

hotspot

Wikipedia

explore

focus